Comparative effectiveness and safety of rivaroxaban in adults with nonvalvular atrial fibrillation

WS Aronow, TA Shamliyan - American Journal of Therapeutics, 2019 - journals.lww.com
Background: All evidence regarding benefits and harms of rivaroxaban for stroke prevention
has not been appraised yet. Study Question: What are the comparative effectiveness and …
被引用次数：6 相关文章

Comparative Effectiveness and Safety of Rivaroxaban in Adults With Nonvalvular Atrial Fibrillation

WS Aronow, TA Shamliyan - American journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Background All evidence regarding benefits and harms of rivaroxaban for stroke prevention
has not been appraised yet. Study question What are the comparative effectiveness and …

Comparative Effectiveness and Safety of Rivaroxaban in Adults With Nonvalvular Atrial Fibrillation

WS Aronow, TA Shamliyan - American Journal of …, 2019 - touroscholar.touro.edu
BACKGROUND: All evidence regarding benefits and harms of rivaroxaban for stroke
prevention has not been appraised yet. STUDY QUESTION: What are the comparative …

Comparative Effectiveness and Safety of Rivaroxaban in Adults With Nonvalvular Atrial Fibrillation.

WS Aronow, TA Shamliyan - American Journal of Therapeutics, 2019 - europepmc.org
Comparative Effectiveness and Safety of Rivaroxaban in Adults With Nonvalvular Atrial
Fibrillation. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …